HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catherine Guittet Selected Research

Renal Tubular Acidosis (Distal Renal Tubular Acidosis)

7/2023Bone mineral density and growth changes in patients with distal renal tubular acidosis after two-years treatment with a new alkalizing drug (ADV7103).
11/2022Improved growth of a child with primary distal renal tubular acidosis after switching from a conventional alkalizing treatment to a new prolonged-release formulation containing potassium citrate and potassium bicarbonate: lessons for the clinical nephrologist.
1/2022Lived experiences of patients with distal renal tubular acidosis treated with ADV7103 and of their caregivers: a qualitative study.
1/2021Correction to: Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.
1/2021Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis.
1/2021Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Catherine Guittet Research Topics

Disease

6Renal Tubular Acidosis (Distal Renal Tubular Acidosis)
07/2023 - 01/2021
2Body Weight (Weight, Body)
01/2023 - 03/2018
1Acidosis
07/2023
1Absence Epilepsy (Childhood Absence Epilepsy)
01/2023
1Hearing Loss (Hearing Impairment)
01/2022
1Rare Diseases (Rare Disease)
01/2022
1Hemolysis
11/2003

Drug/Important Bio-Agent (IBA)

4dirhodium tetraacetate (DRTA)IBA
07/2023 - 01/2021
4Potassium CitrateFDA LinkGeneric
07/2023 - 01/2021
4potassium bicarbonateIBA
07/2023 - 01/2021
2Drug CombinationsIBA
01/2021 - 01/2021
1SugarsIBA
01/2023
1Ethosuximide (Zarontin)FDA LinkGeneric
01/2023
1AcidsIBA
01/2021
1Midazolam (Versed)FDA LinkGeneric
03/2018
1Phosphoinositide Phospholipase CIBA
11/2003

Therapy/Procedure

1Ketogenic Diet
01/2023
1Therapeutics
01/2023